|
FY2025
7 months to Dec 31, 2025
|
|
|---|---|
| Net income | |
| Adjustments to reconcile net income to net cash used in operating activities: | |
| Interest earned on investments held in Trust Account | |
| Formation costs paid by Sponsor in exchange for issuance of Class B ordinary shares | |
| Changes in operating assets and liabilities: | |
| Prepaid expenses | |
| Accounts Payable and Accrued Expenses | |
| Net cash used in operating activities | |
| Cash and investments held in Trust Account | |
| Net cash used in investing activities | |
| Cash Flows from Financing Activities: | |
| Proceeds from sale of Units, net of underwriting discounts paid | |
| Proceeds from sale of Private Units | |
| Proceeds from promissory note – related party | |
| Repayment of promissory note – related party | |
| Funds held by Sponsor | |
| Payment of offering costs | |
| Net cash provided by financing activities | |
| Net Change in Cash | |
| Cash – End of period | |
| Non-Cash investing and financing activities: | |
| Deferred offering costs paid by Sponsor in exchange for the issuance of Class B ordinary shares | |
| Accretion of Class A ordinary shares to redemption value | |
| Deferred underwriting fee |
Loading...
